POA PUBLICATIONS
Clinical validation of a machine-learning derived signature predictive of outcomes from first-line oxaliplatin-based chemotherapy in advanced colorectal cancer
Clinical Cancer Research
The Landscape of Glycogen Synthase Kinase-3 beta (GSK-3b) Genomic Alterations in Cancer
Molecular Cancer Therapeutics
Molecular Characteristics of BRCA1/2 and PALB2 Mutations in Pancreatic Ductal Adenocarcinoma
ESMO Open
Prevalence of Phosphatidylinositol-3-Kinase (PI3K) Pathway Alterations and Co-alteration of Other Molecular Markers in Breast Cancer
Frontiers in Oncology
Experimental Biology and Medicine
Comprehensive genomic profiling of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs)
Clinical Cancer Research
Frequent Mutations of POT1 Distinguish Pulmonary Sarcomatoid Carcinoma From Other Lung Cancer Histologies
Clinical Lung Cancer
Molecular profiling of melanoma brain metastases compared to primary cutaneous melanoma and to extracranial metastases
Oncotarget
Rethinking Clinical Trials Reform During the COVID-19 Pandemic
JAMA Oncology
Primary CNS lymphoma commonly expresses immune
response biomarkers
Neuro-Oncology Advances
POT1 mutation spectrum in tumour types commonly diagnosed among POT1-associated hereditary cancer syndrome families
Journal of Medical Genetics
Comparison of the biomarkers for targeted therapies in primary extra-mammary and mammary Paget’s disease
Cancer Medicine
Immune checkpoint expression, microsatellite instability, and mutational burden: Identifying immune biomarker phenotypes in uterine cancer
Gynecologic Oncology
Comprehensive tumor profiling reveals unique molecular differences between peritoneal metastases and primary colorectal adenocarcinoma
Journal of Surgical Oncology
Molecular variations in uterine carcinosarcomas identify therapeutic opportunities
International Journal of Gynecological Cancer
Molecular Analyses of Left‐ and Right‐Sided Tumors in Adolescents and Young Adults with Colorectal Cancer
The Oncologist
Relationship between MLH1 , PMS2 , MSH2 and MSH6 gene‐specific alterations and tumor mutational burden in 1057 microsatellite instability‐high solid tumors
International Journal of Cancer
WRN-mutated colorectal cancer is characterized by a distinct genetic phenotype
Cancers
The molecular profile of BRCA-mutated biliary tract cancers
ESMO Open – Cancer Horizons
Relationship Between Protein Biomarkers of Chemotherapy Response and Microsatellite Status, Tumor Mutational Burden and PD-L1 Expression in Cancer Patients
International Journal of Cancer
An Emerging Landscape for Canonical and Actionable Molecular Alterations in Primary and Metastatic Prostate Cancer
Molecular Cancer Therapeutics
Molecular Genomic Profiling of Adrenocortical Cancers
in Clinical Practice
Surgery
Population bias in somatic measurement of microsatellite instability status
Cancer Medicine
Actionable co-alterations in breast tumors with pathogenic mutations in the homologous recombination DNA damage repair pathway
Breast Cancer Research and Treatment